Amgen Challenges Novo Nordisk’s Ozempic And Eli Lilly’s Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials

Earnings Scheduled For September 30, 2025

Sumain Faisal5 months ago 0

4 Real Estate Players Recede In Momentum Despite A Fed Rate Cut

Sumain Faisal5 months ago 0

Miami, Dubai Lead Global Real Estate Bubble Risk Surge As Prices Soar Despite Cooling Markets, UBS Warns

Sumain Faisal5 months ago 0

Apple Risks Falling Behind In AI Arms Race, Says Wedbush’s Dan Ives: ‘Biggest Strategic Mistake’ Was Not Buying Netflix

Sumain Faisal5 months ago 0